Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5998)
All Articles published online
|
Publishing Process of This Article
|
May 10, 2014 (publication date) through Sep 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Dearing KR, Sangal A, Weiss GJ. Maintaining clarity: Review of maintenance therapy in non-small cell lung cancer. World J Clin Oncol 2014; 5(2): 103-113 [PMID: 24829857 DOI: 10.5306/wjco.v5.i2.103] |
|---|---|
| URL: | https://www.wjgnet.com/2218-4333/full/v5/i2/103.htm |
| Number | Citing Articles |
| 1 |
Xin Wang, Lan Cheng, Hong-Jun Xie, Rui-Jun Ju, Yao Xiao, Min Fu, Jing-Jing Liu, Xue-Tao Li. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 2018; 46(sup2): 1154 doi: 10.1080/21691401.2018.1481082
|
| 2 |
Hong-Jun Xie, Jing Zhao, DongZhi Zhuo-Ma, NorBu Zhan-Dui, Aga Er-Bu, Tashi Tsering. Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 3465 doi: 10.1080/21691401.2019.1653900
|
| 3 |
KE ZHANG, XIAN WANG, HONGYAN WANG. Effect and mechanism of Src tyrosine kinase inhibitor sunitinib on the drug-resistance reversal of human A549/DDP cisplatin-resistant lung cancer cell line. Molecular Medicine Reports 2014; 10(4): 2065 doi: 10.3892/mmr.2014.2440
|
| 4 |
Janani Ravi, Mohamad Elbaz, Nissar A. Wani, Mohd W. Nasser, Ramesh K. Ganju. Cannabinoid receptor‐2 agonist inhibits macrophage induced EMT in non‐small cell lung cancer by downregulation of EGFR pathway. Molecular Carcinogenesis 2016; 55(12): 2063 doi: 10.1002/mc.22451
|
| 5 |
Ahmed Nagy, Omar Abdel Rahman, Heba Abdullah, Ahmed Negida. Do we Need Maintenance Chemotherapy in Advanced NSCLC in the Era of Immune and Targeted Therapy?. Current Cancer Therapy Reviews 2019; 15(1): 50 doi: 10.2174/1573394714666180417160205
|
| 6 |
Albin Rudisch, Matthew Richard Dewhurst, Luminita Gabriela Horga, Nina Kramer, Nathalie Harrer, Meng Dong, Heiko van der Kuip, Andreas Wernitznig, Andreas Bernthaler, Helmut Dolznig, Wolfgang Sommergruber, João Costa-Rodrigues. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts. PLOS ONE 2015; 10(4): e0124283 doi: 10.1371/journal.pone.0124283
|
| 7 |
Chi-Chin Huang, Han-Pin Kuo, Yueh-E Lin, Shu-Ching Chen. Effects of a Web-based Health Education Program on Quality of Life and Symptom Distress of Initially Diagnosed Advanced Non-Small Cell Lung Cancer Patients: A Randomized Controlled Trial. Journal of Cancer Education 2019; 34(1): 41 doi: 10.1007/s13187-017-1263-y
|
| 8 |
Feng Guo, Zhili Cao, Huiqin Guo, Shanqing Li. The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6052
|
| 9 |
Jing-Jing Liu, Wei Tang, Min Fu, Xiao-Qing Gong, Liang Kong, Xue-Min Yao, Ming Jing, Fu-Yi Cai, Xue-Tao Li, Rui-Jun Ju.
Development of R
8
modified epirubicin–dihydroartemisinin liposomes for treatment of non-small-cell lung cancer
. Artificial Cells, Nanomedicine, and Biotechnology 2019; 47(1): 1947 doi: 10.1080/21691401.2019.1615932
|
| 10 |
Yijie Zhou, Ruji Yao, Bo Yang, Ramachandran Suresh. New Developments in Statistical Modeling, Inference and Application. ICSA Book Series in Statistics 2016; : 91 doi: 10.1007/978-3-319-42571-9_5
|
| 11 |
Sui Huang. The War on Cancer: Lessons from the War on Terror. Frontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00293
|
| 12 |
Peter Csermely, Tamás Korcsmáros, Ruth Nussinov. Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy. Seminars in Cell & Developmental Biology 2016; 58: 55 doi: 10.1016/j.semcdb.2016.07.005
|
| 13 |
Xue-Tao Li, Zhi-Yan Zhou, Ying Jiang, Mei-Li He, Lian-Qun Jia, Lin Zhao, Lan Cheng, Tian-Zhu Jia. PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer. Journal of Drug Targeting 2015; 23(3): 232 doi: 10.3109/1061186X.2014.979829
|
| 14 |
Jie Huang, Juan Peng, Linlang Guo. Non-Coding RNA: A New Tool for the Diagnosis, Prognosis, and Therapy of Small Cell Lung Cancer. Journal of Thoracic Oncology 2015; 10(1): 28 doi: 10.1097/JTO.0000000000000394
|
| 15 |
Derya Kivrak Salim, Hasan Mutlu, Melek Karakurt Eryilmaz, Fatma Yalçin Musri, Deniz Tural, Hasan Şenol Coşkun. Metronomic maintenance chemotherapy in patients presenting with paraneoplastic autoimmune hepatitis with recurrent thymic carcinoma. Journal of Oncology Pharmacy Practice 2016; 22(2): 313 doi: 10.1177/1078155214551318
|
| 16 |
Shu-Ching Chen, Shiuan-Chen Chiou, Chong-Jen Yu, Yun-Hsiang Lee, Wei-Yu Liao, Pei-Yin Hsieh, Sin-Yuan Jhang, Yeur-Hur Lai. The unmet supportive care needs—what advanced lung cancer patients’ caregivers need and related factors. Supportive Care in Cancer 2016; doi: 10.1007/s00520-016-3096-3
|